Separate and joint modeling of longitudinal and event time data using standard computer packages

被引:229
作者
Guo, X
Carlin, BP
机构
[1] Biostat Affymetrix Inc, Santa Clara, CA 95051 USA
[2] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA
基金
美国国家卫生研究院;
关键词
Bayesian approach; joint model; longitudinal data; Markov chain Monte Carlo (MCMC); SAS; survival data; WinBUGS;
D O I
10.1198/0003130042854
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
Many clinical trials and other medical and reliability studies generate both longitudinal (repeated measurement) and survival (time to event) data. Many well-established methods exist for analyzing such data separately, but these may be inappropriate when the longitudinal variable is correlated with patient health status, hence the survival endpoint (as well as the possibility of study dropout). To remedy this, an earlier article proposed a joint model for longitudinal and survival data, obtaining maximum likelihood estimates via the EM algorithm. The longitudinal and survival responses are assumed independent given a linking latent bivariate Gaussian process and available covariates. We develop a fully Bayesian version of this approach, implemented via Markov chain Monte Carlo (MCMC) methods. We use the approach to jointly model the longitudinal and survival data from an AIDS clinical trial comparing two treatments, didanosine (ddI) and zalcitabine (ddC). Despite the complexity of the model, we find it to be relatively straightforward to implement and understand using the WinBUGS software. Wee compare our results to those obtained from readily available alternatives in SAS Procs MIXED, NLMIXED, PHREG, and LIFEREG, as well as Bayesian analogues of these traditional separate likelihood methods. The joint Bayesian approach appears to offer significantly improved and enhanced estimation of median survival times and other parameters of interest, as well as simpler coding and comparable runtimes.
引用
收藏
页码:16 / 24
页数:9
相关论文
共 13 条
  • [1] A COMPARATIVE TRIAL OF DIDANOSINE OR ZALCITABINE AFTER TREATMENT WITH ZIDOVUDINE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    ABRAMS, DI
    GOLDMAN, AI
    LAUNER, C
    KORVICK, JA
    NEATON, JD
    CRANE, LR
    GRODESKY, M
    WAKEFIELD, S
    MUTH, K
    KORNEGAY, S
    COHN, DL
    HARRIS, A
    LUSKINHAWK, R
    MARKOWITZ, N
    SAMPSON, JH
    THOMPSON, M
    DEYTON, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (10) : 657 - 662
  • [2] [Anonymous], 2000, C&H TEXT STAT SCI
  • [3] Cox D. R., 1984, Analysis of survival data
  • [4] Gelman A, 2013, BAYESIAN DATA ANAL, DOI DOI 10.1201/9780429258411
  • [5] Response of CD4 lymphocytes and clinical consequences of treatment using ddI or ddC in patients with advanced HIV infection
    Goldman, AI
    Carlin, BP
    Crane, LR
    Launer, C
    Korvick, JA
    Deyton, L
    Abrams, DI
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 11 (02): : 161 - 169
  • [6] Henderson R, 2000, Biostatistics, V1, P465, DOI 10.1093/biostatistics/1.4.465
  • [7] RANDOM-EFFECTS MODELS FOR LONGITUDINAL DATA
    LAIRD, NM
    WARE, JH
    [J]. BIOMETRICS, 1982, 38 (04) : 963 - 974
  • [8] Latent class models for joint analysis of longitudinal biomarker and event process data: Application to longitudinal prostate-specific antigen readings and prostate cancer
    Lin, HQ
    Turnbull, BW
    McCulloch, CE
    Slate, EH
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2002, 97 (457) : 53 - 65
  • [9] MODELING DISEASE MARKER PROCESSES IN AIDS
    PAWITAN, Y
    SELF, S
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1993, 88 (423) : 719 - 726
  • [10] Bayesian measures of model complexity and fit
    Spiegelhalter, DJ
    Best, NG
    Carlin, BR
    van der Linde, A
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 2002, 64 : 583 - 616